{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T20:35:13Z","timestamp":1778013313438,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"am","delay-in-days":347,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","contactlensjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contact Lens and Anterior Eye"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.clae.2024.102335","type":"journal-article","created":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T12:36:47Z","timestamp":1731933407000},"page":"102335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["LipiFlow for the treatment of dry eye disease: A Cochrane systematic review summary"],"prefix":"10.1016","volume":"48","author":[{"given":"Tsz Wing","family":"Yim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4032-2744","authenticated-orcid":false,"given":"Andrew D.","family":"Pucker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Rueff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna A.","family":"Tichenor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John E.","family":"Conto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clae.2024.102335_b0005","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","article-title":"TFOS DEWS II diagnostic methodology report","volume":"15","author":"Wolffsohn","year":"2017","journal-title":"Ocul Surf"},{"issue":"5","key":"10.1016\/j.clae.2024.102335_b0010","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/ICO.0b013e318225415a","article-title":"Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study","volume":"31","author":"Lemp","year":"2012","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.clae.2024.102335_b0015","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1167\/iovs.10-6997c","article-title":"The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland","volume":"52","author":"Knop","year":"2011","journal-title":"Invest Ophthalmol vis Sci"},{"key":"10.1016\/j.clae.2024.102335_b0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.exer.2017.03.013","article-title":"Structure-function relationship of tear film lipid layer: A contemporary perspective","volume":"163","author":"Georgiev","year":"2017","journal-title":"Exp Eye Res"},{"issue":"4","key":"10.1016\/j.clae.2024.102335_b0025","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1167\/iovs.10-6997f","article-title":"The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee","volume":"52","author":"Tomlinson","year":"2011","journal-title":"Invest Ophthalmol vis Sci"},{"issue":"2","key":"10.1016\/j.clae.2024.102335_b0030","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/ICL.0b013e318242b494","article-title":"Development of the 4-3-2-1 meibum expressibility scale","volume":"38","author":"Meadows","year":"2012","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.clae.2024.102335_b0035","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jtos.2022.01.002","article-title":"Morphological characteristics of meibomian glands and their influence on dry eye disease in contact lens wearers","volume":"24","author":"von Ahrentschildt","year":"2022","journal-title":"Ocul Surf"},{"issue":"4","key":"10.1016\/j.clae.2024.102335_b0040","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1167\/iovs.10-6997g","article-title":"The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction","volume":"52","author":"Geerling","year":"2011","journal-title":"Invest Ophthalmol vis Sci"},{"key":"10.1016\/j.clae.2024.102335_b0045","article-title":"Over the counter (OTC) artificial tear drops for dry eye syndrome","volume":"2","author":"Pucker","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.clae.2024.102335_b0050","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/ICO.0b013e318239aaea","article-title":"A new system, the LipiFlow, for the treatment of meibomian gland dysfunction","volume":"31","author":"Lane","year":"2012","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.clae.2024.102335_b0055","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3109\/02713683.2011.631721","article-title":"A single LipiFlow\u00ae thermal pulsation system treatment improves meibomian gland function and reduces dry eye symptoms for 9 months","volume":"37","author":"Greiner","year":"2012","journal-title":"Cur Eye Res"},{"key":"10.1016\/j.clae.2024.102335_b0060","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.2147\/OPTH.S226168","article-title":"Real-world treatment patterns of cyclosporine ophthalmic emulsion and lifitegrast ophthalmic solution among patients with dry eye","volume":"13","author":"White","year":"2019","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.clae.2024.102335_b0065","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00417-021-05363-1","article-title":"Efficacy and safety of a vectored thermal pulsation system (LipiFlow\u00ae) in the treatment of meibomian gland dysfunction: a systematic review and meta-analysis","volume":"260","author":"Hu","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"10.1016\/j.clae.2024.102335_b0070","article-title":"LipiFlow for the treatment of dry eye disease","volume":"2","author":"Pucker","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clae.2024.102335_b0075","unstructured":"HigginsJ, Savovi\u0107J, PageM, et al. Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JP, Thomas J, Chandler J, et al, eds. Cochrane Handbook for Systematic Reviews of Interventions, version 6.3; updated February 2022. Available at: https:\/\/training.cochrane.org\/handbook\/current\/chapter-08. Accessed July 13, 2024."},{"key":"10.1016\/j.clae.2024.102335_b0080","unstructured":"Sch\u00fcnemann HJ, Higgins JP, Vist GE, et al. Chapter 14: Completing \u2018summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, et al, eds. Cochrane Handbook for Systematic Reviews of Interventions, version 6.3; updated February 2022. Available at: https:\/\/training.cochrane.org\/handbook\/current\/chapter-14. Accessed July 13, 2024."},{"issue":"4","key":"10.1016\/j.clae.2024.102335_b0085","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jfo.2013.12.007","article-title":"Meibomian gland dysfunction: a comparative study of modern treatments","volume":"37","author":"Baumann","year":"2014","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.clae.2024.102335_b0090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.33192\/Smj.2020.11","article-title":"Comparison of an automated thermodynamic treatment system (LipiFlow) and warm compresses for the treatment of moderate severity of meibomian gland dysfunction","volume":"72","author":"Booranapong","year":"2019","journal-title":"Siriraj Med J"},{"key":"10.1016\/j.clae.2024.102335_b0095","first-page":"1324","article-title":"Comparative study between the meibomian pulsation system and the warm compress treatment for MGD","volume":"18","author":"He","year":"2018","journal-title":"International Eye Science"},{"issue":"4","key":"10.1016\/j.clae.2024.102335_b0100","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/j.jcrs.0000000000001124","article-title":"Efficacy of vector thermal pulsation treatment in reducing postcataract surgery dry eye disease in patients affected by meibomian gland dysfunction","volume":"49","author":"Mencucci","year":"2023","journal-title":"J Cataract Refract Surg"},{"issue":"4","key":"10.1016\/j.clae.2024.102335_b0105","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s10792-022-02516-x","article-title":"Efficacy and Safety evaluation of a single thermal pulsation system treatment (LipiFlow\u00ae) on meibomian gland dysfunction: a randomized controlled clinical trial","volume":"43","author":"Meng","year":"2023","journal-title":"Int Ophthalmol"},{"issue":"4","key":"10.1016\/j.clae.2024.102335_b0110","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/ICO.0000000000002837","article-title":"TearCare for the treatment of meibomian gland dysfunction in adult patients with dry eye disease: A masked randomized controlled trial","volume":"41","author":"Gupta","year":"2022","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.clae.2024.102335_b0115","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s40123-021-00431-5","article-title":"Effect of a novel thermostatic device on meibomian gland dysfunction: A randomized controlled trial in Chinese patients","volume":"11","author":"Li","year":"2022","journal-title":"Ophthalmol Ther"},{"issue":"4","key":"10.1016\/j.clae.2024.102335_b0120","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/ICO.0000000000002235","article-title":"A 6-week, prospective, randomized, single-masked study of lifitegrast ophthalmic solution 5% versus thermal pulsation procedure for treatment of inflammatory meibomian gland dysfunction","volume":"39","author":"Tauber","year":"2020","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.clae.2024.102335_b0125","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/OPX.0000000000001892","article-title":"Comparison of two thermal pulsation systems in the treatment of meibomian gland dysfunction: A randomized, multicenter study","volume":"99","author":"Wesley","year":"2022","journal-title":"Optom vis Sci"},{"key":"10.1016\/j.clae.2024.102335_b0130","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.2147\/OPTH.S368319","article-title":"A Comparison of tearcare and LipiFlow systems in reducing dry eye disease symptoms associated with meibomian gland disease","volume":"16","author":"Holland","year":"2022","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.clae.2024.102335_b0135","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.2147\/OPTH.S259692","article-title":"The efficacy between conventional lid hygiene and additional thermal pulsatile system in meibomian gland dysfunction patients treated with long-term anti-glaucoma medications in a randomized controlled trial","volume":"14","author":"Kasetsuwan","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.clae.2024.102335_b0140","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2147\/OPTH.S234008","article-title":"Comparison of the iLUX and the LipiFlow for the treatment of meibomian gland dysfunction and symptoms: a randomized clinical trial","volume":"14","author":"Tauber","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.clae.2024.102335_b0145","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2147\/OPTH.S150433","article-title":"Comparison of a single-dose vectored thermal pulsation procedure with a 3-month course of daily oral doxycycline for moderate-to-severe meibomian gland dysfunction","volume":"12","author":"Hagen","year":"2018","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.clae.2024.102335_b0150","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/archophthalmol.2009.356","article-title":"Minimal clinically important difference for the ocular surface disease index","volume":"128","author":"Miller","year":"2010","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"10.1016\/j.clae.2024.102335_b0155","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/opo.12315","article-title":"The placebo effect: Is it unethical to use it or unethical not to?","volume":"36","author":"Elliott","year":"2016","journal-title":"Ophthalmic Physiol Opt"}],"container-title":["Contact Lens and Anterior Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048424002285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048424002285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T02:28:14Z","timestamp":1742351294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1367048424002285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1367048424002285"],"URL":"https:\/\/doi.org\/10.1016\/j.clae.2024.102335","relation":{},"ISSN":["1367-0484"],"issn-type":[{"value":"1367-0484","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LipiFlow for the treatment of dry eye disease: A Cochrane systematic review summary","name":"articletitle","label":"Article Title"},{"value":"Contact Lens and Anterior Eye","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clae.2024.102335","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 British Contact Lens Association. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102335"}}